Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Clinical study
0
Allocation Type
Randomized
0
Health Conditions in Trial
Diabetes mellitus
0
Liver
0
Intervention Model
Parallel Assignment
0
Interventional Trial Phase
Phase 4
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
Pioglitazone
0
Glyburide
0
Intervention Type
Drug
0
Last Updated
February 28, 2012
0
Masked Party
Care Provider
0
Outcomes Assessor
0
Participant
0
Investigator
0
Masking Type
Quadruple
0
Primary Completion Date
2005
0
Trial Recruitment Size
2,120
0
Trial Sponsor
Takeda
0
Clinical Trial Start Date
2000
0
Study Completion Date
2005
0
Clinical Trial Study Type
Interventional
0
NCT Number
NCT00494312
0
Official Name
A Randomized, Comparator Controlled, Double-Blind Study of the Liver Safety of Pioglitazone HCl vs Glyburide With Metformin and Insulin as Part of Step Therapy in Subjects With Type 2 (Non-Insulin Dependent) Diabetes
0
Official Website
clinicaltrials.gov/study...494312
0
Find more entities like Safety Study of Pioglitazone Compared To Glyburide on Liver Function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE